HIV and noncommunicable diseases (NCDs) in Latin America: A call for an integrated and comprehensive response

Journal of Acquired Immune Deficiency Syndromes

Volumn 67, Issue SUPPL.1, 2014, Pages

  Crabtree Ramírez, Brenda ^a   Del Río, Carlos ^b,c   Grinsztejn, Beatriz ^d   Sierra Madero, Juan ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b EMORY UNIVERSITY   (United States)

^c EMORY UNIVERSITY   (United States)

^d Funda??o Oswaldo Cruz   (Brazil)

Author keywords

aging with HIV; cancer; cardiovascular disease; HIV AIDS; Latin America and the Caribbean; noncommunicable diseases

Indexed keywords

INDINAVIR; TENOFOVIR;

ARTICLE; BREAST CANCER; CANCER MORTALITY; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CHRONIC KIDNEY DISEASE; COMORBIDITY; CREATININE CLEARANCE; FRAMINGHAM RISK SCORE; GOVERNMENT; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTEGRATED HEALTH CARE SYSTEM; KAPOSI SARCOMA; KIDNEY DYSFUNCTION; LIFE EXPECTANCY; LUNG CANCER; METABOLIC SYNDROME X; NON COMMUNICABLE DISEASE; NONHODGKIN LYMPHOMA; PAPILLOMA VIRUS; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; SOUTH AND CENTRAL AMERICA; STOMACH CANCER; UTERINE CERVIX CANCER; WORLD HEALTH ORGANIZATION;

ANTI-RETROVIRAL AGENTS; COMORBIDITY; DELIVERY OF HEALTH CARE, INTEGRATED; HEALTH POLICY; HIV INFECTIONS; HUMANS; LATIN AMERICA; PREVALENCE;

EID: 84906066816     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0000000000000261     Document Type: Article

References (40)

1. Dutta A, Wirtz A, Stanciole A, et al. The global HIV epidemics among people who inject drugs. 2013. Available at: http://www.worldbank.org/content/ dam/Worldbank/document/GlobalHIVEpidemicsAmongPeople WhoInjectDrugs.pdf. Accessed July 8, 2014.
2. Kort R. XVII International AIDS Conference: from evidence to action-AIDS 2008 and the global response to AIDS. J Int AIDS Soc. 2009;12 (suppl 1):S7.
3. Negin J, Martiniuk A, Cumming RG, et al. Prevalence of HIV and chronic comorbidities among older adults. AIDS. 2012;26(suppl 1): S55-S63.
4. Greig J, Casas E, O'Brien D, et al. Association between older age and adverse outcomes on antiretroviral therapy: a cohort analysis of programme data from nine countries. AIDS. 2012;26(suppl 1): S31-S37.
5. Justice AC, Braithwaite RS. Lessons learned from the first wave of aging with HIV. AIDS. 2012;26(suppl 1):S11-S18.
6. Crabtree-Ramirez B, Caro-Vega Y, Shepherd BE, et al. Cross-sectional analysis of late HAART initiation in Latin America and the Caribbean: late testers and late presenters. PLoS One. 2011;6:e20272.
7. Trujillo AJ, Fleisher LK. Beyond income, access, and knowledge: factors explaining the education gradient in prevention among older adults with diabetes and hypertension in Latin America. J Aging Health. 2013;25: 1398-1424.
8. Pacheco AG, Tuboi SH, Faulhaber JC, et al. Increase in non-AIDS related conditions as causes of death among HIV-infected individuals in the HAART era in Brazil. PLoS One. 2008;3:e1531.
9. Grinsztejn B, Luz PM, Pacheco AG, et al. Changing mortality profile among HIV-infected patients in Rio de Janeiro, Brazil: shifting from AIDS to non-AIDS related conditions in the HAART era. PLoS One. 2013;8:e59768.
10. Paula AA, Schechter M, Tuboi SH, et al. Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide data. PLoS One. 2014;9:e94636.
11. Bonilla-Chacin M. Promoting Healthy Living in Latin America and the Caribbean: Governance of Multispectral Activities to Prevent Risk Factors for Noncomunicable Diseases. Directions in Development. Washington, DC: World Bank; 2014.
12. Murray C, Lopez A. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries and Risk Factors in 1990 and Projected to 2020. Cambridge, United Kingdom: Harvard University Press; 1996.
13. Schargrodsky H, Hernandez-Hernandez R, Champagne BM, et al. CAR-MELA: assessment of cardiovascular risk in seven Latin American cities. Am J Med. 2008;121:58-65.
14. De Socio GV, Martinelli L, Morosi S, et al. Is estimated cardiovascular risk higher in HIV-infected patients than in the general population? Scand J Infect Dis. 2007;39:805-812.
15. Cahn P, Leite O, Rosales A, et al. Metabolic profile and cardiovascular risk factors among Latin American HIV-infected patients receiving HAART. Braz J Infect Dis. 2010;14:158-166.
16. Aguilar S, Gómez P, Lerman G, et al. Diagnóstico y tratamiento de las dislipidemias: posición de la Sociedad Mexicana de Nutrición y Endo-crinología. Rev Endocrinol Nutr. 2004;12:1-36.
17. Belloso WH, Orellana LC, Grinsztejn B, et al. Analysis of serious non-AIDS events among HIV-infected adults at Latin American sites. HIV Med. 2010;11:554-564.
18. Albuquerque VM, Zirpoli JC, de Barros Miranda-Filho D, et al. Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case-control study. BMC Infect Dis. 2013;13:274.
19. Fonseca Pacheco AG, Grinsztejn B, Fonseca MDJ, et al. Carotid intima-media thickness (cIMT) in HIV-infected patients in Rio de Janeiro, Brazil: overall and gender analysis. Abstract #MOPE073. Presented at the 7th IAS Confernece on HIV Pathogenesis, Treatment and Prevention. Kuala Lampur, Malaysia, 2013.
20. Ssinabulya I, Kayima J, Longenecker C, et al. Subclinical atherosclerosis among HIV-infected adults attending HIV/AIDS care at two large ambulatory HIV clinics in Uganda. PLoS One. 2014;9:e89537.
21. Mangili A, Polak JF, Skinner SC, et al. HIV infection and progression of carotid and coronary atherosclerosis: the CARE study. J Acquir Immune Defic Syndr. 2011;58:148-153.
22. Volpe GE, Tang AM, Polak JF, et al. Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort. J Acquir Immune Defic Syndr. 2013;64:51-57.
23. Vagenas P, Lama JR, Ludford KT, et al. A systematic review of alcohol use and sexual risk-taking in Latin America. Rev Panam Salud Publica. 2013;34:267-274.
24. Lee JG, Griffin GK, Melvin CL. Tobacco use among sexual minorities in the USA, 1987 to May 2007: a systematic review. Tob Control. 2009;18: 275-282.
25. PAHO. PAHO Plan of Action for Cancer Prevention & Control: Cancer Stakeholders Meeting, Fact Sheet: Cancer in Latin American and the Caribbean. Available at: http://www.paho.org/hq/index.php?option=com- content&view= category&layout=blog&id=3595&Itemid=3637. Accessed July 8, 2014.
26. Bacchi CE, Bacchi M, Rabenhorst SH, et al. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus. Am J Clin Pathol. 1996;105:230-237.
27. Collins JA, Hernandez AV, Hidalgo JA, et al. High proportion of T-cell systemic non-Hodgkin lymphoma in HIV-infected patients in Lima, Peru. J Acquir Immune Defic Syndr. 2005;40:558-564.
28. Ferrera A, Melchers W, Velema J, et al. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras. Am J Trop Med Hyg. 1997;57:138-141.
29. Laurido M, Uruena A, Vizzotti C, et al. Incidence variation in malignancies associated or not with AIDS at an outpatient care center, 1997-2005 [in Spanish]. Medicina (B Aires). 2007;67:243-246.
30. Osorio SG, Montenegro U. Linfomas asociados a infección por virus de inmunodeficiencia humana en un complejo hospitalario de la Región Metropolitana, Chile: 1990-2002 [in Spanish]. Rev Chilena Infectol. 2007;24:117-124.
31. Sampaio J, Brites C, Araujo I, et al. AIDS related malignancies in Brazil. Curr Opin Oncol. 2007;19:476-478.
32. Fink VI, Shepherd BE, Cesar C, et al. Cancer in HIV-infected persons from the Caribbean, Central and South America. J Acquir Immune Defic Syndr. 2011;56:467-473.
33. Melo VH, Guimaraes MD, Rocha GM, et al. Prevalence and risk factors associated with anal intraepithelial neoplasia among HIV-positive men in Brazil. J Low Genit Tract Dis. 2014;18:128-135.
34. Friedman R, Coutinho J, Cunha C, et al. Prevalence of anal human papillomavirus (HPV) infection in a cohort of Brazilian men. Abstract WEPE502. Kuala Lampur, Malaysia: IAS; 2013.
35. Cusumano AM, Gonzalez Bedat MC. Chronic kidney disease in Latin America: time to improve screening and detection. Clin J Am Soc Neph-rol. 2008;3:594-600.
36. Bellorin-Font E, Ambrosoni P, Carlini RG, et al. Clinical practice guidelines for the prevention, diagnosis, evaluation and treatment of mineral and bone disorders in chronic kidney disease (CKD-MBD) in adults. Nefrologia. 2013;33(suppl 1):1-28.
37. Santiago P, Grinsztejn B, Friedman RK, et al. Screening for decreased glomerular filtration rate and associated risk factors in a cohort of HIV-infected patients in a middle-income country. PLoS One. 2014;9:e93748.
38. Ministério da Saúde. Plano de ações estratégicas para o enfrentamento das doenças crônicas não transmissíveis (DCNT) no Brasil 2011-2022. Brasilia, Brasil: Secretaria de Vigilância em Saúde. Departamento de Análise de Sit-uação de Saúde; 2011: 1-148. Available at: http://www.paho.org/bra/index. php?option=com-content&view=article&id= 2337&Itemid=1. Accessed July 10, 2014.
39. Paltiel AD, Weinstein MC, Kimmel AD, et al. Expanded screening for HIV in the United States-an analysis of cost-effectiveness. N Engl J Med. 2005;352:586-595.
40. Moyer VA. Screening for HIV: U.S. preventive services task force recommendation statement. Ann Intern Med. 2013;159:51-60.